glp-1 employer coverage news october 2025 Approaches to Medicare GLP-1 Drug Coverage -

Anatomical images were acquired using a T 2 -Turbo-RARE scan, TR = 2230 ms, TE = 39.43 ms, FOV = 20 7.9 mm 2 , slices: 23, slice thickness = 0.3 mm, matrix size = 200 79

Importantly, despite the evidence for use of SGLT-2 inhibitors for DKD treatment, they should not be used in patients with type 1 diabetes because of the risk of euglycaemic diabetic ketoacidosis

N Engl J Med (2017) 377:64457

This is literally the same mechanism that GLP-1 medications are activating just from the other direction

(The recommended dietary daily allowance is around 0.36 grams per body pound of body weight.) You may notice that the quality of your skin looks and feels different, too

Stem Cells and Development, 17 (4), 805814